A detailed history of Violich Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Violich Capital Management, Inc. holds 4,412 shares of NVS stock, worth $487,614. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,412
Previous 4,412 -0.0%
Holding current value
$487,614
Previous $470,000 7.87%
% of portfolio
0.07%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$95.27 - $108.47 $15,433 - $17,572
162 Added 3.81%
4,412 $427,000
Q3 2022

Oct 17, 2022

SELL
$74.61 - $87.26 $29,844 - $34,904
-400 Reduced 8.6%
4,250 $323,000
Q1 2022

Apr 25, 2022

SELL
$80.11 - $90.62 $7,209 - $8,155
-90 Reduced 1.9%
4,650 $408,000
Q3 2021

Oct 12, 2021

BUY
$81.78 - $95.14 $65,424 - $76,112
800 Added 20.3%
4,740 $388,000
Q2 2021

Jul 29, 2021

SELL
$85.24 - $94.15 $68,192 - $75,320
-800 Reduced 16.88%
3,940 $359,000
Q3 2020

Oct 19, 2020

SELL
$82.14 - $91.0 $259,233 - $287,196
-3,156 Reduced 39.97%
4,740 $412,000
Q2 2020

Aug 03, 2020

BUY
$80.93 - $91.1 $12,625 - $14,211
156 Added 2.02%
7,896 $690,000
Q1 2020

Apr 30, 2020

BUY
$70.67 - $99.01 $21,201 - $29,703
300 Added 4.03%
7,740 $638,000
Q4 2018

Feb 12, 2019

BUY
$73.66 - $82.02 $18,415 - $20,505
250 Added 3.48%
7,440 $638,000
Q3 2018

Nov 08, 2018

SELL
$66.94 - $77.43 $28,114 - $32,520
-420 Reduced 5.52%
7,190 $619,000
Q2 2018

Aug 03, 2018

SELL
$64.91 - $73.36 $5,841 - $6,602
-90 Reduced 1.17%
7,610 $575,000
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $7,414 - $7,727
-100 Reduced 1.28%
7,700 $661,000
Q2 2017

Aug 14, 2017

BUY
N/A
7,800
7,800 $0

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Violich Capital Management, Inc. Portfolio

Follow Violich Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.